Award
National Cancer Institute 5R01CA292407-02
Assessment of DCAF15 role in Acute Myeloid Leukemia
Recipient
Not specified
Award Amount
$468,135.00
Ceiling
$468,135.00
Awarded
March 26, 2026
Identifier
5R01CA292407-02
Award for research project on the role of DCAF15 in Acute Myeloid Leukemia funded by the National Cancer Institute with a budget of $468,135.
Description
This project aims to understand the role of DCAF15 in AML and develop small molecule degraders targeting DCAF15. The award is funded by the National Cancer Institute, with a total budget of $468,135 for fiscal year 2026. The project duration is from April 1, 2025, to March 31, 2030.